Workflow
pediatrix(MD)
icon
Search documents
pediatrix(MD) - 2019 Q2 - Earnings Call Transcript
2019-08-04 20:31
Mednax, Inc. (NYSE:MD) Q2 2019 Earnings Conference Call August 1, 2019 10:00 AM ET Company Participants Charles Lynch - Vice President-Strategy and Investor Relations Roger Medel - Chief Executive Officer Stephen Farber - Chief Financial Officer Conference Call Participants AJ Rice - Credit Suisse Ralph Giacobbe - Citi Kevin Fischbeck - Bank of America Jason Plagman - Jefferies Pito Chickering - Deutsche Bank Gary Taylor - JP Morgan Tao Qiu - Stifel Matthew Gillmor - Baird Whit Mayo - UBS Operator Ladies an ...
pediatrix(MD) - 2019 Q2 - Quarterly Report
2019-08-01 20:30
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-12111 MEDNAX, INC. (Exact name of registrant as specified in its charter) Florida 26-3667538 (State or other jurisdiction ...
pediatrix(MD) - 2019 Q1 - Earnings Call Transcript
2019-05-03 22:20
Mednax, Inc. (NYSE:MD) Q1 2019 Earnings Conference Call May 2, 2019 10:00 AM ET Company Participants Charles Lynch ??? Vice President-Strategy and Investor Relations Roger Medel ??? Chief Executive Officer Stephen Farber ??? Chief Financial Officer Conference Call Participants A.J. Rice ??? Credit Suisse Ralph Giacobbe ??? Citigroup Jason Plagman ??? Jefferies Pito Chickering ??? Deutsche Bank Ana Gupte ??? SVB Leerink Chad Vanacore ??? Stifel Joanna Gajuk ??? Bank of America John Ransom ??? Raymond James ...
pediatrix(MD) - 2019 Q1 - Quarterly Report
2019-05-02 20:23
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Table of Contents Commission File Number: 001-12111 MEDNAX, INC. (Exact name of registrant as specified in its charter) Florida 26-3667538 (State or other jurisdictio ...
Mednax (MD) Presents At Raymond James 40th Institutional Investors Conference - Slideshow
2019-03-04 22:03
March 4, 2019 Raymond James & Associates' 40th Annual Institutional Investor Conference Charles Lynch Vice President, Strategy and Investor Relations, MEDNAX, Inc. 1 @ Forward looking disclosure 1 Certain statements and information in this presentation may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward- ...
Mednax (MD) Presents At JP Morgan High Yield and Leveraged Finance Conference - Slideshow
2019-02-28 17:22
| --- | --- | --- | --- | --- | --- | |-------|-------|--------------------------------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | J.P. Morgan 2019 Global High Yield & Leveraged Finance Conference | | | | | | | Executive Vice President and Chief Financial Officer, MEDNAX, Inc. | | | | | | | | | | | 1 Forward looking disclosure 1 Certain statements and information in this presentation may be deemed to ...
pediatrix(MD) - 2018 Q4 - Annual Report
2019-02-14 21:21
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12111 MEDNAX, INC. (Exact name of registrant as specified in its charter) FLORIDA 26-3667538 (State or other jurisdiction of inco ...
pediatrix(MD) - 2018 Q4 - Earnings Call Transcript
2019-02-07 22:59
Mednax, Inc. (NYSE:MD) Q4 2018 Earnings Conference Call February 7, 2019 10:00 AM ET Company Participants Charles Lynch - Vice President Strategy and Investor Relations Roger Medel - CEO Stephen Farber - CFO Conference Call Participants Ralph Giacobbe - Citigroup Jason Plagman - Jefferies A.J. Rice - Credit Suisse Kevin Fischbeck - Bank of America Ana Gupte - SVB Leerink Gary Taylor - JPMorgan John Ransom - Raymond James Pito Chickering - Deutsche Bank Operator Ladies and gentlemen, thank you for standing b ...